Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

NCT00306150 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Loss, Surgical
Postoperative Hemorrhage

Interventions

DRUG: Trasylol (Aprotinin, BAYA0128)
DRUG: Placebo

Sponsor

Bayer